CIPO trademark

MELVIZO

FiledCIPOWord markClass 5

"MELVIZO" is a word mark owned by Samsung Bioepis Co., Ltd., filed at the CIPO on May 7, 2025. It is filed and waiting for examination and covers class 5 (Pharmaceuticals).

View Samsung Bioepis Co., Ltd. portfolioGet this data via the API
Official CIPO record
MELVIZO
Word mark as filed with the CIPO
Status
Filed
Since February 3, 2026
Filed
May 7, 2025
Registered
Not yet
Expires
Not recorded
Application no.
2396911
Registration no.
Not yet
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns MELVIZO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Samsung Bioepis Co., Ltd.

South Korea

120 trademarks in the portfolioView company

Representative

Gowling WLG (Canada) LLP

Gowling WLG (Canada) LLP

Goods and services

What the mark covers

The products and services MELVIZO is filed for, grouped by Nice class.

  • Pharmaceuticals for the treatment of eye diseases, disorders, and conditions; medicines for human purposes for the treatment of retinal diseases, eye diseases and conditions, ocular disorders and diseases, and for ocular or intraocular surgery; pharmaceutical preparations for the treatment of eye diseases, disorders, and conditions; eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; ophthalmic preparations; pharmaceutical preparations for treating diabetes; human vaccine preparations; biological tissue cultures for medical purposes; pharmaceutical preparations for the treatment of inflammatory eye diseases; antidiabetic preparations; pharmaceutical preparations for treating metabolic syndrome; pharmaceutical preparations for the treatment of eye diseases caused by diseases of the metabolic system; pharmaceutical preparations for the prevention of ocular disorders; pharmaceutical preparations for the prevention of ocular diseases; cardiovascular pharmaceutical preparations for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases; dietary supplements for general health and well being

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Examiner's First Report
  2. Search Recorded
  3. Pre-Assessment Letter Sent; Retired Goods or Services
  4. Formalized
  5. Created
  6. Filed
FAQ

About MELVIZO

Who owns the trademark "MELVIZO"?

The CIPO trademark "MELVIZO" (application 2396911) is owned by Samsung Bioepis Co., Ltd.

What is the status of "MELVIZO"?

Its status at the CIPO is: filed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull MELVIZO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019deb58-34b4-766f-9863-bd1255a693fe
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019deb58-34b4-766f-9863-bd1255a693fe",
  "object": "trademark",
  "mark_text": "MELVIZO",
  "status": {
    "primary": "pending",
    "stage": "filed"
  },
  "office_code": "CA",
  "application_number": "2396911",
  "filing_date": "2025-05-07",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "SAMSUNG BIOEPIS CO., LTD.",
      "entity_id": "ent_019eb7c8-63f6-758a-8736-c654508d57c5"
    }
  ]
}